scholarly journals Occupation and relative risk of cutaneous squamous cell carcinoma (cSCC): A 45-year follow-up study in 4 Nordic countries

2016 ◽  
Vol 75 (3) ◽  
pp. 548-555 ◽  
Author(s):  
Jose Hernán Alfonso ◽  
Jan Ivar Martinsen ◽  
Eero Pukkala ◽  
Elisabete Weiderpass ◽  
Laufey Tryggvadottir ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Relative Risk ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Nordic Countries ◽  
Follow Up Study

Patients with low-risk cutaneous squamous cell carcinoma do not require extended out-patient follow-up

2017 ◽  
Vol 70 (6) ◽  
pp. 852-855 ◽  
Author(s):  
A.M. Rose ◽  
K.J. Nicoll ◽  
A. Moinie ◽  
D.J. Jordan ◽  
A.T. Evans ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Low Risk

scholarly journals Bilateral Diffuse Uveal Melanocytic Proliferation in a Woman with Metastatic Scalp Squamous Cell Carcinoma Treated with Cemiplimab

2021 ◽  
pp. 961-966
Author(s):  
Etti Katzburg ◽  
Dinah Zur ◽  
Orit Gutfeld ◽  
Ilya Kirgner ◽  
Zohar Habot-Wilner
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Visual Loss ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Fundus Examination ◽  
First Case ◽  
Appropriate Treatment ◽  
Underlying Malignancy

Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a rare paraneoplastic intraocular syndrome that causes progressive visual loss in patients driven by an IgG factor associated with an underlying malignancy. The IgG factor – cultured melanocyte elongation and proliferation – was found in the IgG fraction of the serum of BDUMP patients. It has been shown to be involved in melanocytic proliferation. In this case report, we describe the first case of BDUMP related to metastatic cutaneous squamous cell carcinoma (cSCC) of the scalp. A 61-year-old woman complained of decreased vision in both of her eyes, while being treated with cemiplimab (an anti-PD-1 therapy) for metastatic cSCC. Fundus examination showed hypopigmented lesions in a leopard pattern and pigmentary clumps in both eyes. Further imaging confirmed the diagnosis of BDUMP. The patient was successfully treated with plasmapheresis. During follow-up, cataract progressed in both eyes, and she underwent cataract surgery with visual acuity improvement to 20/20. BDUMP is a challenging diagnosis especially in patients treated with anti-PD-1 immunotherapy as it can be confused with drug-related effects. It is crucial to distinguish between the cases in order to allow the appropriate treatment which includes continuation of systemic anti-PD-1 for the underlying malignancy and plasmapheresis therapy for BDUMP.

Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases

2000 ◽  
Vol 28 (6) ◽  
pp. 331-335 ◽  
Author(s):  
Dominique Gomez ◽  
Alain Faucher ◽  
Véronique Picot ◽  
François Siberchicot ◽  
Jean-Louis Renaud-Salis ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Follow Up Study

Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus.A prospective follow-up study from Linxian, China

Cancer ◽  
1994 ◽  
Vol 74 (6) ◽  
pp. 1686-1692 ◽  
Author(s):  
Sanford M. Dawsey ◽  
Klaus J. Lewin ◽  
Guo-Qing Wang ◽  
Fu-Sheng Liu ◽  
Roberta K. Nieberg ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Follow Up Study ◽  
Subsequent Risk
Sign in / Sign up

Export Citation Format

Share Document